We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,066

Federal Circuit Again Reverses PTAB Obviousness Determination
  • Foley & Lardner LLP
  • USA
  • February 14 2017

In what is becoming a familiar basis for reversal of PTAB decisions, the Federal Circuit yet again reversed the PTAB for its failure to adequately


Federal Circuit Finds "Consisting Of" Requires Reversing Infringement Of Shire Lialda Patent
  • Foley & Lardner LLP
  • USA
  • February 14 2017

The Federal Circuit focused on the “consisting of” language in the claims at issue when it reversed the district court’s finding that Watson’s ANDA


Waiting for Gorsuch: SCOTUS Kicks Important Class-Action Waiver Case to Next Term
  • Foley & Lardner LLP
  • USA
  • February 13 2017

Last week, the United States Supreme Court informed litigants in Epic Systems Corp. v. Lewis that it is pushing the case to its October 2017 term


Four Hot Labor and Employment Issues in Automotive for 2017 - Part 1
  • Foley & Lardner LLP
  • USA
  • February 13 2017

It hasn’t taken long, and if there was ever any wonder, it’s been put to rest. In the first weeks of the Trump administration we’ve seen


U.S. Customs and the New Trump Administration: Your Top Ten Questions Answered
  • Foley & Lardner LLP
  • USA
  • February 7 2017

During the campaign, U.S. Customs & Border Protection (CBP) was mostly mentioned by President Trump in the context of illegal immigration


The CFPB's Prospect RESPA Consent Orders: Eight Key Takeaways
  • Foley & Lardner LLP
  • USA
  • February 6 2017

The Consumer Financial Protection Bureau (CFBP) on January 31, 2017, issued consent orders settling enforcement claims that a major mortgage lender


Wisconsin Supreme Court Addresses Expert Testimony Under Daubert
  • Foley & Lardner LLP
  • USA
  • February 9 2017

Six years after the Wisconsin legislature amended Wis. Stat. 907.02(1) to adopt the federal Daubert standard for admission of expert testimony, the


Court Rejects Theory Of Derivation Based On FDA Requirement
  • Foley & Lardner LLP
  • USA
  • February 7 2017

The Federal Circuit decision in Cumberland Pharmaceuticals Inc. v. Mylan Institutional LLC may be more interesting for what Mylan argued than for


False Advertising Liability for Affiliate Marketing
  • Foley & Lardner LLP
  • USA
  • September 27 2016

The proliferation of e-commerce websites along with the rise of social media, blogging, and online communities has greatly increased the importance


Federal Circuit Finds Infringement Under Akamai Of Two-Step Method Of Treatment
  • Foley & Lardner LLP
  • USA
  • January 24 2017

In Eli Lilly & Co. v. Teva Parenteral Medicines, Inc., the Federal Circuit affirmed the district court decision finding infringement under Akamai of